Correlation Between Orient Pharma and Maxigen Biotech

Can any of the company-specific risk be diversified away by investing in both Orient Pharma and Maxigen Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Orient Pharma and Maxigen Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Orient Pharma Co and Maxigen Biotech, you can compare the effects of market volatilities on Orient Pharma and Maxigen Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Orient Pharma with a short position of Maxigen Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Orient Pharma and Maxigen Biotech.

Diversification Opportunities for Orient Pharma and Maxigen Biotech

0.42

Correlation Coefficient

Orient Pharma  Maxigen Biotech

Very weak diversification

The 3 months correlation between Orient and Maxigen is 0.42. Overlapping area represents the amount of risk that can be diversified away by holding Orient Pharma Co and Maxigen Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Maxigen Biotech and Orient Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Orient Pharma Co are associated (or correlated) with Maxigen Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Maxigen Biotech has no effect on the direction of Orient Pharma i.e., Orient Pharma and Maxigen Biotech go up and down completely randomly.

Pair Corralation between Orient Pharma and Maxigen Biotech

Assuming the 90 days trading horizon Orient Pharma Co is expected to generate 3.44 times more return on investment than Maxigen Biotech. However, Orient Pharma is 3.44 times more volatile than Maxigen Biotech. It trades about 0.14 of its potential returns per unit of risk. Maxigen Biotech is currently generating about 0.13 per unit of risk. If you would invest  2,590  in Orient Pharma Co on September 23, 2024 and sell it today you would earn a total of  1,110  from holding Orient Pharma Co or generate 42.86% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Orient Pharma Co  vs.  Maxigen Biotech

Orient Pharma

Risk-Adjusted Performance

11 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Orient Pharma Co are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Orient Pharma showed solid returns over the last few months and may actually be approaching a breakup point.

Maxigen Biotech

Risk-Adjusted Performance

10 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Maxigen Biotech are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Maxigen Biotech may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with Orient Pharma and Maxigen Biotech

The main advantage of trading using opposite Orient Pharma and Maxigen Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Orient Pharma position performs unexpectedly, Maxigen Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Maxigen Biotech will offset losses from the drop in Maxigen Biotech's long position.

The idea behind Orient Pharma Co and Maxigen Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.